MacroGenics (MGNX)

Executive Summary

MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. More Details


Snowflake Analysis

Excellent balance sheet with limited growth.

Search for a company to compare.